NCT07685067 · NOT YET RECRUITING

LifeBio Memory: Development of a Reminiscence Therapy Online Platform With Machine Learning to Increase Engagement

This trial tests a mobile app called LifeBio Memory that helps older adults with mild cognitive impairment record and share their life stories using audio and visual prompts. Researchers want to know whether the app improves quality of life, reduces depression and loneliness, and strengthens bonds between caregivers and the people they care for. This is a feasibility and development study, not a late-stage clinical trial, so results will shape future research rather than prove a treatment works.

Eligibility criteria

The investigators will enroll a total of 84 older adult participants and 84 informal caregivers across the 84 dyads, comprising 21 Hispanic/Latino dyads, 21 Korean dyads, 21 Black dyads, and 21 Non-Hispanic White dyads.
The inclusion and exclusion criteria for older adult participants are:
1. Self-identified as Hispanic/Latino, Korean, Black/African American, and Non-Hispanic White
2. Speak and read Spanish, Korean, or English
3. Aged 60 years and older, with Montreal Cognitive Assessment (MoCA) test scores ranging 18-30 (with MCI: 18-25, or at risk for MCI: 26-30)
4. Have a local or in-home informal caregiver who can participate who is age 18 or older
5. No pre-existing acute psychotic disease or critical illness
6. Consent to participate
The inclusion and exclusion criteria for informal caregivers are:
1. Self-identified as Hispanic/Latino, Korean, Black/African American, and Non-Hispanic White
2. Speak and read Spanish, Korean, or English
3. Aged 18 years and older
4. Currently serving as the primary informal caregiver for older adults aged 60 or older
5. No pre-existing acute psychotic disease or critical illness
6. Consent to participate

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2026-07-06

View full record on ClinicalTrials.gov

All APOE4 clinical trials